Cancer Research 09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 1243-1250, June 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuchino, Y.
Right arrow Articles by Nishimura, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuchino, Y.
Right arrow Articles by Nishimura, S.

Comparison of the Specificity and Extent of in Vitro Methylation by Guanylate Residue-specific Transfer RNA Methylases Isolated from Ascites Hepatoma, 3'-Methyl-4-dimethylaminoazobenzene-induced Hepatoma, and Normal Rat Liver1

Yoshiyuki Kuchino2, Hideya Endo and Susumu Nishimura

The Biology Division, National Cancer Center Research Institute, Chuo-ku, Tokyo, and Japan [S. N.] Cancer Research Institute, Faculty of Medicine, Kyushu University, Fukuoka, Japan [Y. K., H. E.]

The extent and sites of in vitro methylation of guanylate residue-specific tRNA methylases isolated from ascites hepatoma, 3'-methyl-4-dimethylaminoazobenzene-induced hepatoma, and normal rat liver were compared by the use of purified individual Escherichia coli tRNA's as methyl acceptors. The levels of activity of the two methylases, i.e., methylases II and III, were 2- to 4-fold higher in the extract from ascites hepatoma and from 3'-methyl-4-dimethylaminoazobenzene-induced hepatoma than in that from normal rat liver. It was shown that the lower level of methylase activity detected in normal rat liver was not due to the increased amount of methylase inhibitor or RNase. The sites of in vitro methylation of E. coli tRNAfMet and tRNAFormula by the tumor methylases were the same as those for normal liver; namely, G27 of tRNAfMet and G10 of tRNAFormula were methylated to provide 2-methylguanosine by methylases II and III, respectively, from tumor cells, as in the case of the methylases from normal liver. These results indicate that specificity of the tRNA methylases, in terms of recognition of location of guanylate residues in tRNA molecules, was not altered in cancerous cells.

1 This investigation was supported in part by grants from the Princess Takamatsu Cancer Research Fund and the Japanese Ministry of Education.

2 Present address: Biology Division, National Cancer Research Institute, Chuo-ku, Tokyo, Japan.

Received 12/17/71. Accepted 2/16/72.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.